Published mark
ANGIODYNAMICS INC
NASDAQ: ANGO. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:68b0ab90-a96c-4fb4-91ca-e83cadf91de9
- SEC CIK
- 0001275187
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 20, 2026
- Newest evidence
- Sep 25, 2025
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- James C. ClemmerSince Jul 18, 2025
- Chair
- Not published
- Independent
- 7 / 88 directors published
- Published claims
- 333 distinct sources
- Evidence records
- 90 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 9 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Chad T. Campbell executive of ANGIODYNAMICS INC, effective 2025-07-18.
EffectiveEffective Jul 18, 2025E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Senior Vice President and General Manager, Oncology and Interventional Devices | Chad T. Campbell | Jul 2025 | current | Source reportedE3 |
| President and Chief Executive Officer | James C. Clemmer | Jul 2025 | current | Source reportedE4 |
| Senior Vice President and General Manager, Cardiovascular and International | Laura Piccinini | Jul 2025 | current | Source reportedE5 |
| Senior Vice President, Chief Legal Officer Corporate Secretary | Lawrence T. Weiss | Jul 2025 | current | Source reportedE6 |
| Executive Vice President and Chief Financial Officer | Stephen A. Trowbridge | Jul 2025 | current | Source reportedE7 |
| Senior Vice President, Global Supply Chain, Quality and Regulatory Affairs | Warren G. Nighan | Jul 2025 | current | Source reportedE8 |
Board of directors
Evidence8 directors published. 7 of 8 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Eileen O. Auen | Independent | 2016 | Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Howard W. Donnelly | Independent | 2004 | None published | Source reportedE2 |
| James C. Clemmer | Not independent | 2016 | None published | Source reportedE2 |
| Jan Stern Reed | Independent | 2016 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE2 |
| Karen A. Licitra | Independent | 2019 | AuditAudit; CompensationCompensation | Source reportedE2 |
| Lorinda A. Burgess | Independent | 2023 | AuditAudit; CompensationCompensation | Source reportedE2 |
| Michael E. Tarnoff, MD | Independent | 2019 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Wesley E. Johnson, Jr. | Independent | 2007 | Audit, chairAudit · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Wesley E. Johnson, Jr. | Wesley E. Johnson, Jr., Jan Stern Reed, Karen A. Licitra, Lorinda A. Burgess | Not described in the published record |
| Audit · Chair; Nominating and Governance | Not published | Wesley E. Johnson, Jr. | Not described in the published record |
| Audit; Compensation | Not published | Karen A. Licitra, Lorinda A. Burgess | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Jan Stern Reed | Not described in the published record |
| Compensation | Eileen O. Auen | Eileen O. Auen, Karen A. Licitra, Lorinda A. Burgess, Michael E. Tarnoff, MD | Not described in the published record |
| Compensation · Chair; Nominating and Governance | Not published | Eileen O. Auen | Not described in the published record |
| Compensation; Nominating and Governance | Not published | Michael E. Tarnoff, MD | Not described in the published record |
| Nominating and Governance | Jan Stern Reed | Jan Stern Reed, Eileen O. Auen, Michael E. Tarnoff, MD, Wesley E. Johnson, Jr. | Not described in the published record |
Committee RecordAudit: Chair Wesley E. Johnson, Jr.; Members Wesley E. Johnson, Jr. (Chair); Jan Stern Reed; Karen A. Licitra; Lorinda A. Burgess
Committee AppointmentWesley E. Johnson, Jr.: chair, Audit
Committee AppointmentJan Stern Reed: member, Audit
Committee AppointmentKaren A. Licitra: member, Audit
Committee AppointmentLorinda A. Burgess: member, Audit
Committee RecordCompensation: Chair Eileen O. Auen; Members Eileen O. Auen (Chair); Karen A. Licitra; Lorinda A. Burgess; Michael E. Tarnoff, MD
Committee AppointmentEileen O. Auen: chair, Compensation
Committee AppointmentKaren A. Licitra: member, Compensation
Committee AppointmentLorinda A. Burgess: member, Compensation
Committee AppointmentMichael E. Tarnoff, MD: member, Compensation
Committee RecordNominating and Governance: Chair Jan Stern Reed; Members Jan Stern Reed (Chair); Eileen O. Auen; Michael E. Tarnoff, MD; Wesley E. Johnson, Jr.
Committee AppointmentJan Stern Reed: chair, Nominating and Governance
Committee AppointmentEileen O. Auen: member, Nominating and Governance
Committee AppointmentMichael E. Tarnoff, MD: member, Nominating and Governance
Committee AppointmentWesley E. Johnson, Jr.: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerJames C. Clemmer, President and Chief Executive Officer, from Jul 18, 2025
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingANGO (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 20, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameANGIODYNAMICS INC
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Chad T. CampbellSenior Vice President and General Manager, Oncology and Interventional Devicescompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:13
- James C. ClemmerPresident and Chief Executive Officercompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:14
- Laura PiccininiSenior Vice President and General Manager, Cardiovascular and Internationalcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:15
- Lawrence T. WeissSenior Vice President, Chief Legal Officer Corporate Secretarycompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:16
- Stephen A. TrowbridgeExecutive Vice President and Chief Financial Officercompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:17
- Warren G. NighanSenior Vice President, Global Supply Chain, Quality and Regulatory Affairscompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:18
- Eileen O. AuenDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:5
- Howard W. DonnellyDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:6
- James C. ClemmerDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:7
- Jan Stern ReedDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:8
- Karen A. LicitraDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:9
- Lorinda A. BurgessDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:10
- Michael E. Tarnoff, MDDirectorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:11
- Wesley E. Johnson, Jr.Directorcompany:68b0ab90-a96c-4fb4-91ca-e83cadf91de9:leadership_role:12
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 9 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 20, 2026. Cited by 4 Claims.
- E2sec proxy. Published Sep 25, 2025. Retrieved Apr 24, 2026. Cited by 8 Claims.
- E3sec filing. Published Jul 18, 2025. Retrieved May 14, 2026. Cited by 1 Claim.
- E4sec filing. Published Jul 18, 2025. Retrieved May 14, 2026. Cited by 1 Claim.
- E5sec filing. Published Jul 18, 2025. Retrieved May 14, 2026. Cited by 1 Claim.
- E6sec filing. Published Jul 18, 2025. Retrieved May 14, 2026. Cited by 1 Claim.
- E7sec filing. Published Jul 18, 2025. Retrieved May 14, 2026. Cited by 1 Claim.
- E8sec filing. Published Jul 18, 2025. Retrieved May 14, 2026. Cited by 1 Claim.
- E9board_seats. board seats. Cited by 15 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 20, 2026- Chad T. Campbell executive of ANGIODYNAMICS INC, effective 2025-07-18.
- James C. Clemmer executive of ANGIODYNAMICS INC, effective 2025-07-18.
- Laura Piccinini executive of ANGIODYNAMICS INC, effective 2025-07-18.
- Lawrence T. Weiss executive of ANGIODYNAMICS INC, effective 2025-07-18.
- Stephen A. Trowbridge executive of ANGIODYNAMICS INC, effective 2025-07-18.
- Warren G. Nighan executive of ANGIODYNAMICS INC, effective 2025-07-18.
- Lorinda A. Burgess seat on ANGIODYNAMICS INC, effective 2023-01-01.
- Lorinda A. Burgess member of Audit; Compensation, effective 2023-01-01.
- Karen A. Licitra seat on ANGIODYNAMICS INC, effective 2019-01-01.
- Michael E. Tarnoff, MD seat on ANGIODYNAMICS INC, effective 2019-01-01.
- Audit; Compensation committee of ANGIODYNAMICS INC, effective 2019-01-01.
- Karen A. Licitra member of Audit; Compensation, effective 2019-01-01.
- Compensation; Nominating and Governance committee of ANGIODYNAMICS INC, effective 2019-01-01.
- Michael E. Tarnoff, MD member of Compensation; Nominating and Governance, effective 2019-01-01.
- Eileen O. Auen seat on ANGIODYNAMICS INC, effective 2016-01-01.
- James C. Clemmer seat on ANGIODYNAMICS INC, effective 2016-01-01.
- Jan Stern Reed seat on ANGIODYNAMICS INC, effective 2016-01-01.
- Audit; Nominating and Governance · Chair committee of ANGIODYNAMICS INC, effective 2016-01-01.
- Jan Stern Reed member of Audit; Nominating and Governance · Chair, effective 2016-01-01.
- Compensation · Chair; Nominating and Governance committee of ANGIODYNAMICS INC, effective 2016-01-01.
- Eileen O. Auen member of Compensation · Chair; Nominating and Governance, effective 2016-01-01.
- Wesley E. Johnson, Jr. seat on ANGIODYNAMICS INC, effective 2007-01-01.
- Audit · Chair; Nominating and Governance committee of ANGIODYNAMICS INC, effective 2007-01-01.
- Wesley E. Johnson, Jr. member of Audit · Chair; Nominating and Governance, effective 2007-01-01.
- Howard W. Donnelly seat on ANGIODYNAMICS INC, effective 2004-01-01.